The United States has purchased virtually all of its stock over the next three months of Remdesivir, one of two drugs that work against Covid-19, leaving none for the rest of the world.
This unilateral gesture by the Trump government has alarmed experts and activists about the implications this may have, for example, for a possible coronavirus vaccine, as the US has shown that it is willing to do anything to secure its medical supplies.
This drug is manufactured by the US company Gilead and has been shown to be effective in 68% of patients. In the United States it has been used since May 1, at zero cost since the company donated the Remdesivir. As of July, it will start charging the stipulated prices, while in Europe the drug is under rapid review awaiting approval, but the European Medicines Agency has already recommended its marketing since last week.